Post-market Assessment of Biodesign Dural Repair Grafts
Post-market Clinical Data Collection Plan for the Biodesign® Dural and Duraplasty Grafts
Sponsor: Cook Research Incorporated
Listed as NCT04057157, this observational or N/A phase trial focuses on Cerebrospinal Fluid Leak and remains completed. Sponsored by Cook Research Incorporated, it has been updated 13 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Nov 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2022 — Nov 2022 [monthly]
Active Not Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Active Not Recruiting
▶ Show 8 earlier versions
-
Apr 2022 — Jul 2022 [monthly]
Active Not Recruiting
-
Jan 2022 — Apr 2022 [monthly]
Active Not Recruiting
-
Oct 2021 — Jan 2022 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Feb 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2019 — Feb 2020 [monthly]
Recruiting
-
Oct 2019 — Nov 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Oct 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cook Research Incorporated
For direct contact, visit the study record on ClinicalTrials.gov .